ArticleIndian pacing and electrophysiology journal
Ganglionated plexus ablation of the left atrium for refractory vasovagal syncope: Analysis of the Safety, Effectiveness and Related Factors.
Article in Indian pacing and electrophysiology journal. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Ganglionated plexus ablation for refractory vasovagal syncope: Moving from "promising" to "protocolized".Indian pacing and electrophysiology journalArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo investigate the safety and efficacy of ganglionated plexus ablation of the left atrium for patients with refractory vasovagal syncope.
methodsFrom May 2019 to December 2023, 39 patients with refractory vasovagal syncope (VVS) underwent ganglionated plexus (GP) ablation at our institution. Associations between post-ablation VVS recurrence and factors including average heart rate on Holter monitoring, preoperative head-up tilt table test (HUTT), for GP identification methods, and sex were analyzed.
resultsDuring the follow-up period 18.7 months, 30 of the 39 patients (76.9 % vs 23.1 %, p = 0.001) were symptom-free after GP ablation. The remaining 9 patients exhibited significant symptomatic improvement, with a marked reduction in the number of syncopal episodes (2.11 ± 1.27 vs 7.13 ± 3.57, p = 0.00). The mean heart rate after procedure (87.10 ± 11.22 bpm) was significantly higher than pre-procedures (70.33 ± 7.56 bpm, p = 0.00), indicating effective VVS control. Preoperative HUTT classifications and GP localization methods showed no significant association with recurrence, although female sex was associated with a higher likelihood of recurrent VVS. No procedure-related complication occurred.
conclusionGP ablation of the left atrium is a safe and effective treatment for patients with refractory vasovagal syncope.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.